The live attenuated varicella-zoster virus vaccine vOka: Molecular and cellular biology of its skin attenuation
Infection with varicella-zoster virus (VZV) causes chickenpox and shingles, both manifesting as a blistering skin rash. The skin is central to VZV, as the site of viral replication, transmission from cell-free virus in blisters and as the gateway to sensory nerves for establishing latency. The exist...
Saved in:
| Main Authors: | Cristina Tommasi, Andriani Drousioti, Judith Breuer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2482286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence of Varicella Zoster Virus Reactivation in Children With Arterial Ischemic Stroke: Results of the VIPS II Study
by: Heather J. Fullerton, et al.
Published: (2025-03-01) -
Expanded spectrum of varicella disease and the need for vaccination in India
by: Padma Srikanth, et al.
Published: (2024-12-01) -
A rare case of acute liver failure due to disseminated Varicella-Zoster Virus (VZV) infection
by: Harris T. Feldman, et al.
Published: (2025-01-01) -
Varicella-zoster virus vasculopathy: a rare complication of Ramsay Hunt Syndrome: a literature review
by: Di Wu, et al.
Published: (2025-06-01) -
Increase in Adult Patients with Varicella Zoster Virus–Related Central Nervous System Infections, Japan
by: Ayami Yoshikane, et al.
Published: (2024-12-01)